Dieter Kube

18.8k total citations · 1 hit paper
76 papers, 3.2k citations indexed

About

Dieter Kube is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Dieter Kube has authored 76 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 34 papers in Immunology and 31 papers in Oncology. Recurrent topics in Dieter Kube's work include Lymphoma Diagnosis and Treatment (34 papers), Immune Cell Function and Interaction (25 papers) and Viral-associated cancers and disorders (16 papers). Dieter Kube is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), Immune Cell Function and Interaction (25 papers) and Viral-associated cancers and disorders (16 papers). Dieter Kube collaborates with scholars based in Germany, United Kingdom and United States. Dieter Kube's co-authors include Hans Tesch, Martina Vockerodt, Grant Gallagher, Joyce Eskdale, Casper Paludan, Christian Münz, Dorothee Schmid, Markus Landthaler, Thomas Tuschl and Volker Diehl and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Communications.

In The Last Decade

Dieter Kube

75 papers receiving 3.2k citations

Hit Papers

Endogenous MHC Class II Processing of a Viral Nuclear Ant... 2004 2026 2011 2018 2004 200 400 600

Peers

Dieter Kube
Olivia M. Martinez United States
Mary M. Tomayko United States
Pavel Pisa Sweden
William Damsky United States
Mark Birkenbach United States
Olivia M. Martinez United States
Dieter Kube
Citations per year, relative to Dieter Kube Dieter Kube (= 1×) peers Olivia M. Martinez

Countries citing papers authored by Dieter Kube

Since Specialization
Citations

This map shows the geographic impact of Dieter Kube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Kube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Kube more than expected).

Fields of papers citing papers by Dieter Kube

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Kube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Kube. The network helps show where Dieter Kube may publish in the future.

Co-authorship network of co-authors of Dieter Kube

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Kube. A scholar is included among the top collaborators of Dieter Kube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Kube. Dieter Kube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stevanato, Gabriele, et al.. (2023). Real-time cell metabolism assessed repeatedly on the same cells via para-hydrogen induced polarization. Chemical Science. 14(28). 7642–7647. 6 indexed citations
3.
Rosenberger, Albert, et al.. (2019). Global, pathway and gene coverage of three Illumina arrays with respect to inflammatory and immune-related pathways. European Journal of Human Genetics. 27(11). 1716–1723. 2 indexed citations
4.
Klingenberg, Marcel, Jürgen Becker, Sonja Eberth, Dieter Kube, & Jörg Wilting. (2014). The NADPH Oxidase Inhibitor Imipramine-Blue in the Treatment of Burkitt Lymphoma. Molecular Cancer Therapeutics. 13(4). 833–841. 23 indexed citations
5.
Vockerodt, Martina, Frederike von Bonin, Wolfram Klapper, et al.. (2013). Aberrant Lymphocyte Enhancer–Binding Factor 1 Expression Is Characteristic for Sporadic Burkitt’s Lymphoma. American Journal Of Pathology. 182(4). 1092–1098. 29 indexed citations
6.
Kreuz, Markus, Nils Schoof, Frederike von Bonin, et al.. (2012). Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non–Hodgkin Lymphoma. Clinical Cancer Research. 18(13). 3637–3647. 32 indexed citations
7.
Heath, Emily, Sridhar Chaganti, Debbie Croom-Carter, et al.. (2012). Epstein-Barr Virus Infection of Naïve B Cells In Vitro Frequently Selects Clones with Mutated Immunoglobulin Genotypes: Implications for Virus Biology. PLoS Pathogens. 8(5). e1002697–e1002697. 56 indexed citations
8.
Schrader, Alexandra, Katharina Meyer, Frederike von Bonin, et al.. (2012). Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas. Cell Communication and Signaling. 10(1). 43–43. 13 indexed citations
9.
Hoffmann, Marion, Markus Schirmer, Mladen V. Tzvetkov, et al.. (2010). A Functional Polymorphism in the NAD(P)H Oxidase Subunit CYBA Is Related to Gene Expression, Enzyme Activity, and Outcome in Non–Hodgkin Lymphoma. Cancer Research. 70(6). 2328–2338. 21 indexed citations
10.
Holtick, Udo, Martina Vockerodt, Nils Schoof, et al.. (2005). STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis. Leukemia. 19(6). 936–944. 76 indexed citations
11.
Paludan, Casper, Dorothee Schmid, Markus Landthaler, et al.. (2004). Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy. Science. 307(5709). 593–596. 674 indexed citations breakdown →
12.
Vockerodt, Martina, et al.. (2004). The Epstein‐Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP‐10: Importance of mRNA half‐life regulation. International Journal of Cancer. 114(4). 598–605. 40 indexed citations
13.
Draube, Andreas, Ronald R. Pfister, Martina Vockerodt, et al.. (2001). Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement. Annals of Hematology. 80(2). 83–89. 23 indexed citations
14.
Vockerodt, Martina, Birgit Haier, Peter Buttgereit, Hans Tesch, & Dieter Kube. (2001). The Epstein–Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38/SAPK2 Pathway. Virology. 280(2). 183–198. 76 indexed citations
15.
Kube, Dieter, et al.. (2001). Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene. Genes and Immunity. 2(4). 181–190. 51 indexed citations
16.
Hess, Sigrun, Hans Smola, Dirk Hadaschik, et al.. (2000). Loss of IL-6 Receptor Expression in Cervical Carcinoma Cells Inhibits Autocrine IL-6 Stimulation: Abrogation of Constitutive Monocyte Chemoattractant Protein-1 Production. The Journal of Immunology. 165(4). 1939–1948. 42 indexed citations
18.
Knethen, Andreas von, Harry F. Abts, Dieter Kube, Volker Diehl, & Hans Tesch. (1997). Expression of p56 lck in B-Cell Neoplasias. Leukemia & lymphoma. 26(5-6). 551–562. 19 indexed citations
19.
Kube, Dieter. (1997). Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions. Nucleic Acids Research. 25(16). 3375–3376. 44 indexed citations
20.
Kube, Dieter, et al.. (1993). Properties of two epithelial cell lines derived from HPV-associated cervical and vulvar lesions. European Journal of Cancer. 29(12). 1746–1753. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026